[Asn670,Leu671]-Amyloid β//A4 Protein Precursor770 (667-675) peptide
Not For Human Use, Lab Use Only.
Cat.#: 314298
Special Price 182.10 USD
-
Product Name
[Asn670,Leu671]-Amyloid β//A4 Protein Precursor770 (667-675) peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
SEVNLDAEF
-
Sequence
Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe
-
Length (aa)
9
-
Peptide Purity (HPLC)
96.7%
-
Molecular Formula
C44H66N10O18
-
Molecular Weight
1023.07
-
Source
Synthetic
-
Form
Powder
-
Description
The peptide [Asn670,Leu671]-Amyloid //A4 Protein Precursor770 (667-675), corresponding to the sequence SEVNLDAEF, represents a variant of the wild-type β-amyloid peptide (BAP) junctional motif. This sequence incorporates a double mutation where the lysine-methionine (KM) residues at positions 670-671 of the amyloid precursor protein (APP) are replaced by asparagine-leucine (NL). In enzymatic studies, this mutant peptide is cleaved specifically at the leucine-aspartate (L/D) bond by the serine proteases cathepsin G and chymotrypsin under acidic conditions. This proteolytic event generates a fragment with an aspartate residue at its amino terminus, analogous to the cleavage observed in the wild-type motif that produces the amino terminus of BAP.
The substitution of NL for KM alters the proteolytic susceptibility of the junctional region. Unlike the wild-type peptide, cathepsins B, D, and L do not cleave this mutant sequence. The cleavage at L/D by cathepsin G and chymotrypsin suggests that these enzymes can process the mutant APP variant, potentially contributing to the generation of BAP-like fragments with a homogeneous amino-terminal aspartate. This biochemical characteristic highlights the role of specific peptide bonds and local sequence context in directing proteolytic processing within the APP molecule.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Sahasrabudhe SR, Brown AM, Hulmes JD, Jacobsen JS, Vitek MP, Blume AJ, Sonnenberg JL. Enzymatic generation of the amino terminus of the beta-amyloid peptide. J Biol Chem. 1993 Aug 5;268(22):16699-705. PMID: 8344949.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"